REPLY: Cardiac Events Associated With Chimeric Antigen Receptor T Cells (CAR-T)

被引：0
|
作者：
Alvi, Raza M.
Fradley, Michael G.
Frigault, Matthew J.
Locke, Frederick L.
Neilan, Tomas G. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Cardiooncol Program, 165 Cambridge St,Suite 400, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Cardiovasc Imaging Res Ctr CIRC, 165 Cambridge St,Suite 400, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 19期
关键词：
D O I：
10.1016/j.jacc.2020.03.045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2523 / 2524
页数：2
相关论文
共 50 条
  • [41] Cardiac adverse events associated with chimeric antigen receptor T- cell therapy
    Thotamgari, Sahith Reddy
    Grewal, Udhayvir Singh
    Shaik, Likhita
    Dominic, Paari
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 57 : 225 - 226
  • [42] EEG Findings in Chimeric Antigen Receptor T-Cell (CAR-T) Related Encephalopathy Syndrome
    Satyanarayan, Sammita
    Markert, Matthew
    Hovsepian, Dominic
    Post, David
    Muffly, Lori
    Miklos, David
    Thomas, Reena
    Scott, Brian
    NEUROLOGY, 2019, 92 (15)
  • [43] A narrative review of chimeric antigen receptor-T (CAR-T) cell therapy for lung cancer
    Liu, Yujia
    He, Yayi
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (09)
  • [44] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Giulia Bonaldo
    Nicola Montanaro
    Domenico AlbertoVaccheri
    European Journal of Clinical Pharmacology, 2021, 77 : 1225 - 1234
  • [45] Financial toxicity among chimeric antigen receptor T-cell therapy (CAR-T) patients
    Crowder, Sylvia
    Hoogland, Aasha
    Quast, Troy
    Turner, Kea
    Irizarry-Arroyo, Nathaly
    Rodriguez, Yvelise
    Logue, Jennifer
    Locke, Frederick
    Jim, Heather
    PSYCHO-ONCOLOGY, 2021, 30 : 37 - 37
  • [46] Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities
    Xia, An-Liang
    Wang, Xiao-Chen
    Lu, Yi-Jun
    Lu, Xiao-Jie
    Sun, Beicheng
    ONCOTARGET, 2017, 8 (52): : 90521 - 90531
  • [47] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Bonaldo, Giulia
    Montanaro, Nicola
    Vaccheri, Alberto
    Motola, Domenico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1225 - 1234
  • [48] New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometry
    Maryamchik, Elena
    Gallagher, Kathleen Mary Ellen
    Preffer, Frederic I.
    Kadauke, Stephan
    Maus, Marcela V.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2020, 98 (04) : 299 - 327
  • [49] Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T-cell therapy
    Patel, Nikita P.
    Dalal, Prarthana J.
    Meng, Zhiying
    Baldridge, Abigail S.
    Cascino, Gregory J.
    Sunderraj, Ashwin
    Sinha, Arjun
    Karmali, Reem
    Feinstein, Matthew J.
    Akhter, Nausheen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 102 - 110
  • [50] BRAIN MRI FINDINGS IN PATIENTS TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) DURING SEVERE NEUROTOXICITY
    Mokhtari, Sepideh
    Arrington, John
    Asquith, Justin
    Bachmeier, Christina
    Locke, Frederick
    Lazaryan, Aleksandr
    NEURO-ONCOLOGY, 2019, 21 : 181 - 182
12345